Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07176078

Evaluating the Added Benefit of Osteopathic Care to a Flexi-FODMAP Diet in Fibromyalgia Patients With Irritable Bowel Syndrome

Led by Universitair Ziekenhuis Brussel · Updated on 2026-04-17

96

Participants Needed

1

Research Sites

73 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Dietary modifications are often recommended as first-line treatment for irritable bowel syndrome, with the FODMAP diet being the most effective intervention to improve global gastrointestinal symptoms. Due to the heterogeneity of symptoms, patients often seek complementary or alternative therapies. This randomized clinical trial aims to determine whether osteopathic care provides additional improvement in gastrointestinal symptoms compared to sham osteopathic care, when both are combined with a flexible FODMAP diet. The trial will also assess the safety and tolerability of osteopathic care. The main questions it aims to answer are: Does osteopathic care reduce IBS symptom severity more than sham osteopathic care? Does osteopathic care improve pain, quality of life, anxiety, fatigue, work productivity, and gut microbiota compared to sham osteopathic care? Do participants adhere to the flexible FODMAP diet and osteopathic care, and are the effects of osteopathic care maintained at 3- and 6-months post-intervention? Can pretreatment factors, such as sociodemographic characteristics, IBS severity, predominant symptoms, psychological state, or gut microbiota composition, predict response to osteopathic care? What adverse effects occur with osteopathic care compared to sham care? Participants will: Visit the osteopathy clinic to receive four sessions of real or sham osteopathic care Complete online assessments before and after the intervention, and at 3- and 6-months post-intervention Provide stool samples before and after the four osteopathic or sham sessions Keep a three-day food diary and a ten-day stool diary before and after the intervention, and at 3- and 6-months post-intervention

CONDITIONS

Official Title

Evaluating the Added Benefit of Osteopathic Care to a Flexi-FODMAP Diet in Fibromyalgia Patients With Irritable Bowel Syndrome

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must be over 18 years old
  • Have a medical diagnosis of irritable bowel syndrome by a doctor using Rome IV criteria
  • Have an IBS Symptom Severity Score (IBS-SSS) of 175 or higher indicating moderate to severe IBS
  • Have a diagnosis of fibromyalgia or meet the 2016 American College of Rheumatology criteria for fibromyalgia with chronic widespread pain lasting 3 months or more
  • Participants may use probiotics and follow a lactose-reduced diet if their intake remains stable throughout the study
  • IBS medications including antidepressants are allowed if used consistently at stable doses for at least 2 to 3 months prior to the study
  • Must be willing to adjust current dietary habits to participate in the study
Not Eligible

You will not qualify if you...

  • Have other gastrointestinal disorders like inflammatory bowel disease or celiac disease that explain symptoms
  • Have diseases affecting gastrointestinal function including history of bariatric surgery
  • Have allergies or food hypersensitivities other than lactose intolerance
  • Have major dietary restrictions or food allergies
  • Are pregnant or planning pregnancy during the trial period (next seven months)
  • Have a body mass index (BMI) less than 18 kg/m²
  • Have previously received osteopathic care for IBS or are already following a FODMAP diet

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Vrije Universiteit Brussel

Brussels, Brussels Capital, Belgium, 1090

Actively Recruiting

Loading map...

Research Team

E

Evert Zinzen, PhD

CONTACT

I

Ishtiaq Ahmed

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here